Although abdominal aortic aneurysm takes place in individuals over the age of 60, there are cases taking place in individuals in the age range of 40 – 50 as well although very few. This number will tend to increase in the coming years if individuals do not make any changes to their lifestyle. The current lifestyle of people is one of the main reasons as to why abdominal aortic aneurysm takes place.
In terms of incidence, North America has the highest percentage of abdominal aortic aneurysm and is expected to remain the highest contributor till the end of the forecast period. There is however investment in R&D across the globe for the development of drugs for abdominal aortic aneurysm which will add to the growth of the market during the forecast period.
The Abdominal Aortic Aneurysm market can be segmented based on type of treatment Surgery, Open surgery, Endovascular aneurysm, Medication, Antihypertensive, Antilipidemics. The Abdominal Aortic Aneurysm market has been segmented based on the location of where the treatments can take place, Hospitals and Clinics. The market has been segmented based on the following geographies. North America, South America, APAC, Europe, Middle East and Africa.
Following is a small list of companies that are changing the landscape of the abdominal aortic aneurysm:
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Abdominal Aortic Aneurysm Treatment - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Abdominal Aortic Aneurysm Treatment - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Abdominal Aortic Aneurysm Treatment Market
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Abdominal Aortic Aneurysm Treatment Market - Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Abdominal Aortic Aneurysm Treatment Market- By type of treatment:
6.1.1. Open Surgery
6.1.2. Endovascular Aneurysm repair
7. Abdominal Aortic Aneurysm Treatment Market- By location of treatment
8. Abdominal Aortic Aneurysm Treatment Market- By Geography:
8.2. Global Study
8.3.1. North America
9. Market Entropy
9.1. New Product Launches
9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles
10.5. Celgen Corporation
10.6. GlaxoSmithKline Pharmaceuticals Limited
10.7. Merc & Co
10.8. Mylan N.V.
10.9. Novartis Pharmaceuticals
10.12. Teva pharmaceutical Industries
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11.3. Research Methodology
11.5. Compilation of Expert Insights
- Celgen Corporation
- GlaxoSmithKline Pharmaceuticals Limited
- Merc & Co
- Mylan N.V.
- Novartis Pharmaceuticals
- Teva pharmaceutical Industries